CYP2C9 and breast cancer: Several genetic polymorphisms in genes such as cytochrome-P450 (CYP)2C8 and CYP2C9, may influence survival after cancer diagnosis due to their role in the metabolism of various breast cancer drugs, including tamoxifen and chemotherapy (Jin et al, 2005).